NovaBay Pharmaceuticals, Inc.
NBY · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,210 | -$6,145 | -$10,608 | -$5,824 |
| Dep. & Amort. | $381 | $356 | $483 | $119 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $220 | $1,153 |
| Change in WC | -$595 | -$433 | $533 | -$38 |
| Other Non-Cash | $2,241 | $1,961 | $2,718 | -$4,602 |
| Operating Cash Flow | -$5,183 | -$4,261 | -$6,654 | -$9,192 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$19 | -$112 | -$52 |
| Net Acquisitions | $1,070 | $0 | $0 | -$11,993 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $1,064 | -$19 | -$112 | -$12,045 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,490 | $1,526 | -$105 | $105 |
| Stock Issued | $3,105 | $565 | $0 | $1,776 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$115 | -$181 | $4,738 | $14,908 |
| Financing Cash Flow | $1,500 | $1,910 | $4,633 | $16,789 |
| Forex Effect | $125 | -$68 | $0 | $0 |
| Net Chg. in Cash | -$2,494 | -$2,438 | -$2,133 | -$4,448 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,924 | $5,362 | $7,979 | $12,427 |
| End Cash | $430 | $2,924 | $5,846 | $7,979 |
| Free Cash Flow | -$5,189 | -$4,280 | -$6,766 | -$9,244 |